Tavaborole: First Global Approval
作者： Anthony Markham
DOI: 10.1007/S40265-014-0276-7
关键词: Dermatology 、 Medicine 、 Pharmacology toxicology 、 Bridged Bicyclo Compounds 、 Foot Dermatosis 、 Tavaborole 、 Antifungal drug 、 Topical treatment 、 Drug approval
摘要: Tavaborole is a novel, low-molecular weight oxaborole antifungal drug under development by Anacor Pharmaceuticals Inc. for the topical treatment of onychomycosis toenail. The has received its first global approval this indication in US. This article summarizes milestones tavaborole leading to toenails.
springer.com
sci-hub.se 参考文章(4)
Boni Elewski, David Pariser, Phoebe Rich, Richard Scher, Current and emerging options in the treatment of onychomycosis. Seminars in Cutaneous Medicine and Surgery. ,vol. 32, ,(2013) , 10.12788/J.SDER.0016
Boni E Elewski, Antonella Tosti, Tavaborole for the treatment of onychomycosis Expert Opinion on Pharmacotherapy. ,vol. 15, pp. 1439- 1448 ,(2014) , 10.1517/14656566.2014.921158
F. L. Rock, W. Mao, A. Yaremchuk, M. Tukalo, T. Crepin, H. Zhou, Y.-K. Zhang, V. Hernandez, T. Akama, S. J. Baker, J. J. Plattner, L. Shapiro, S. A. Martinis, S. J. Benkovic, S. Cusack, M. R. K. Alley, An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site. Science. ,vol. 316, pp. 1759- 1761 ,(2007) , 10.1126/SCIENCE.1142189
Xiaoying Hui, Stephen J. Baker, Ronald C. Wester, Sherry Barbadillo, Anne K. Cashmore, Virginia Sanders, Karin M. Hold, Tsutomu Akama, Yong‐Kang Zhang, Jacob J. Plattner, Howard I. Maibach, In Vitro Penetration of a Novel Oxaborole Antifungal (AN2690) Into the Human Nail Plate Journal of Pharmaceutical Sciences. ,vol. 96, pp. 2622- 2631 ,(2007) , 10.1002/JPS.20901